Novacyt (LON: NCYT), an international specialist in clinical diagnostics, new CEO David Allmond joins Proactive London to discuss their unaudited trading update for the year ended 31 December 2021.
David Allmond’s also talks about his first 100 days with the company - together with a strategy update.
Reported revenues and EBITDA for the period are both expected to be in line with expectations with the 2021 audited full year results expected in the week commencing 25 April 2022.